: 

Join us on June 27 and 28, 2017 for the exclusive COPD Spotlight interactive live webinars: “COPD Spotlight Webinar - where are we with personalized medicine in COPD?” to be broadcast in English.
Objectives
This live, interactive event will give you the opportunity to listen to global experts discuss: recommendations for ICS use and withdrawal according to the GOLD 2017 major revisions; practical advice on prescribing and withdrawing ICS in clinical practice; the relationship between patient and device; and data associating device use and patient outcomes
Program
Spotlight on the contribution of ICS in COPD patients (20 min)
Spotlight on why inhaler device matters (20 min)
Q&A (20 min)
Timing of live interactive webinars
You will have four opportunities to choose from to attend the COPD Spotlight Webinar:
Tuesday, 27 June
 Live webinar 1 17:00–18:00
 Live webinar 2 21:00–22:00
Wednesday, 28 June
 Live webinar 3 10:00–11:00
 Live webinar 4 12:00–13:00
This is your personal invite: please do not forward this link on
Please click to register for
Live webinar 1 - Live webinar 2 - Live webinar 3 - Live webinar 4
Once registered to your chosen event, please use the same
link to access the webinar on the day of the event!
Faculty
COPD Spotlight Webinars
Live webinar program
Professor Peter Kardos
Red Cross Maingau Hospital, Frankfurt, Germany
Peter Kardos, MD, is head of Group Practice and the Department for Respiratory Medicine at the Red Cross Maingau Hospital, Frankfurt, Germany. He specializes in internal medicine, allergology, and sleep medicine. His areas of interest include chronic cough, asthma, COPD, diffuse parenchymal lung diseases, allergy, and clinical pharmacology.
Professor Kardos studied medicine at the University of Vienna, with internships and training in internal medicine and allergy in Germany between 1971 and 1977. He then lectured at the University of Bonn, before joining Maingau Hospital in Frankfurt in 1979.
He has participated in a large number of national and international clinical studies as an investigator, principal investigator or as a member of the Steering Committee, and has been involved in the design of several large national and international multicenter studies.
He is the first author or co-author of several German evidence-based guidelines, and is a member of numerous national and international organizations, including Deutsche Gesellschaft für Pneumologie, Deutsche Atemwegsliga, Deutsche Gesellschaft für Allergie und Immunitätsforschung, the European Respiratory Society, the European Academy of Allergy and Clinical Immunology, and the American Thoracic Society. Professor Kardos is co-editor of Pneumologie, and has authored over 60 scientific articles in national and international journals.
Professor Mathieu Molimard
University of Bordeaux, Bordeaux, France
Mathieu Molimard, MD, PhD is head of the Pharmacology Department at the University Hospital of Bordeaux, France, and specialized in Pneumology and Pharmacology. His areas of research include the use, adherence and efficacy of medicines in a real-life setting. He has a particular interest in respiratory treatments and targeted therapeutics and the measurement and optimization of their performance in real-life settings.
Professor Molimard studied medicine at the Pitié Salpêtrière Faculty of Medicine (Paris). He then specialized in Pneumology as a resident of the Paris teaching hospitals and subsequently whilst a registrar at the Saint Louis hospital and Lariboisière Faculty of Medicine (Paris) in parallel to studying Pharmacology (Université Paris V). In 1996 he became a University Lecturer and in 2000 Professor of Clinical Pharmacology at the University of Bordeaux.
He is Associate Director of the Department of Pharmacology of Bordeaux. This department has over 100 members of staff and is constituted of: Clinical Pharmacology and Pharmacoepidemiology research units, Laboratories for Experimental pharmacology, Toxicology and Therapeutic Drug Monitoring as well as regional Pharmacovigilance and Pharmacodependence Centres. Professor Molimard develops fundamental and applied research projects in Respiratory Pharmacology as a team-leader in the Experimental Pharmacology Laboratory.
He is also, from 2007, in charge of Biology of the Bordeaux Teaching Hospitals and Member of the Hospital Board. He has been a member of the French Transparency Commission, a member of the Pneumology-ENT work group for Market Authorization (a position that he has held for more than ten years) and is president of the French College of Medical Pharmacology. Professor Molimard is the author of over 140 scientific articles.

: 

Invitation: